FHTX
FHTX
US3441741077
Foghorn Therapeutics Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 30.909.000 22.602.000
36.8%
Cost of Revenue -- --
--
Gross Profit -- --
--
113.016.000 122.887.000
8.0%
Operating Income -82.107.000 -100.285.000
18.1%
Pretax Income -74.283.000 -86.620.000
14.2%
Net Income Common Stockholders -74.283.000 -86.620.000
14.2%
-- --
--
-- --
--
ende